×

Growth Reports

Growth Reports
Report Name

Cell based Assays Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Products and Services (Reagents, Assay Kits, Microplates, Probes & Labels, Instruments & Software, Cell Lines), By Application (Basic Research, Drug Discovery, Other Applications), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs)), Countries and Companies Report

Cell based Assays is projected to register a 9.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0009126  |   No. of Pages: 205

Cloning and Mutagenesis Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Cloning Kits, Mutagenesis Kits, Others), By Technology (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others), By End-user (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes), Countries and Companies Report

Cloning and Mutagenesis Market is projected to register a 19.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0009125  |   No. of Pages: 200

Clinical Oncology Next Generation Sequencing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges), By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Application (Screening, Companion Diagnostics, Others), By End-user (Hospitals, Clinics, Laboratories), Countries and Companies Report

Clinical Oncology Next Generation Sequencing Market is projected to register a 15.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0009124  |   No. of Pages: 200

COVID 19 Detection PoC Kits Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030 – By Test Type, By Application, By Distribution Channel, By End-User, By Region, and Companies Report 2023

Key market players in the COVID-19 Detection PoC Kits market include established diagnostic companies biotechnology firms, and emerging startups. These companies are continuously investing in research and development to enhance the accuracy, sensitivity, and specificity of their kits.

Published On: October, 2024  |   Report Code: USD0009120  |   No. of Pages: 200

Consumer Genomics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Genetic relatedness, Ancestry, Lifestyle, Wellness, & Nutrition, Diagnostics, Sports Nutrition & Health, Reproductive Health, Personalized Medicine & Pharmacogenetic testing, Others), Countries and Companies Report

Consumer Genomics Market is projected to register a 23.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0009118  |   No. of Pages: 200

Digital Biology Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030 – By Application, By Type, By End User, By Region, and Companies Report 2023

The digital biology market exhibits regional variations in terms of adoption, technological advancements, and market dynamics. North America and Europe lead in terms of innovation and established ecosystems, while Asia Pacific is experiencing rapid growth.

Published On: October, 2024  |   Report Code: USD0009117  |   No. of Pages: 200

Custom Antibody Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Service (Antibody Development, Antigen Preparation, Immunization & Hybridoma Production, Antibody Characterization, Antibody Production & Purification, Antibody Labeling), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others), By Source (Mice, Rabbit, Others), By Application (Research, Therapeutics), By Indication (Oncology, Infectious Diseases, Immunology, Neurobiology, Cardiovascular Diseases, Others), By End-User (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Contract Research Organizations), Countries and Companies Report

Custom Antibody is projected to register a 9.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0009115  |   No. of Pages: 205

CRISPR and Cas Genes Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Kits & Enzymes, Vector-based Cas, DNA-free Cas, Libraries, Design Tool, Antibodies, Others), By Service (Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA synthesis), By Application (Biomedical, Agricultural), By End-user (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, Contract Research Organizations (CROs)), Countries and Companies Report

CRISPR and Cas Genes Market is projected to register a 20.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0009114  |   No. of Pages: 200

DNA and Gene Chip Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others), By Product (Consumables, Instrumentation), By End-User (Academic & Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Others), Countries and Companies Report

DNA and Gene Chip is projected to register a 10.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0009111  |   No. of Pages: 205

DNase, Ligase, and RNA Polymerases Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By DNases Application (Biopharmaceutical processing, Others), By Ligases Application (Oligonucleotide synthesis, Others), By RNA Polymerases Application (mRNA production, Others), Countries and Companies Report

DNase, Ligase, and RNA Polymerases Market is projected to register a 8.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0009109  |   No. of Pages: 200

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us